Status:

UNKNOWN

Efficacy and Safety Study of Metronidazole, Nystatin and Dexamethasone Combination Therapy in Bacterial and Fungal Vaginal Infections

Lead Sponsor:

Marjan Industria e Comercio ltda

Conditions:

Bacterial Vaginosis

Fungal Vaginal Infections

Eligibility:

FEMALE

18-50 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the efficacy and safety of association of metronidazole, nystatin and dexamethasone in the treatment of bacterial and fungal vaginal infections.

Eligibility Criteria

Inclusion

  • Post-menarche women and premenopausal women, between 18 and 50 years old;
  • Diagnosis of bacterial vaginosis (Amsel criteria), fungal (positive KOH test)or mixed vaginal infection;
  • Patients who have regular menstrual cycles (patients with regular menstrual cycles with intervals between 21 to 35 days, duration of 1 to 7 days)

Exclusion

  • Patients who have a known hypersensitivity to components of the formula ;
  • Pregnant and lactating women ;
  • Patients with other vaginal infections, such as infection by Trichomonas vaginalis , C. trachomatis, Neisseria gonorrhoeae , herpes or HPV.
  • Knowledge of positive test result for human immunodeficiency virus ;
  • Patients in treatment of cervical intraepithelial neoplasia or carcinoma of the cervix ;
  • Patients who have undergone gynecological procedures in the month prior to inclusion (such as cauterization of the cervix , cervical biopsy, high-frequency surgery) ;
  • Patients with other vaginal or vulvar conditions that may confound interpretation of clinical response;
  • Patients who received intravaginal or systemic antimicrobial or antifungal therapy 14 days before randomization ;
  • Patients on immunosuppressive medications (such as corticosteroids , cyclosporine , etc. ) ;
  • Known or suspected cancer ;
  • Participation in any experimental study or ingestion of any experimental drug 12 months before the start of this study.

Key Trial Info

Start Date :

January 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2017

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT02186145

Start Date

January 1 2016

End Date

January 1 2017

Last Update

April 9 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Faculty of Medicine of ABC (FMABC)

Santo André, São Paulo, Brazil, 09190-615